ArticleFrontiers in oncology2026
Metastatic malignant melanoma presenting as bilateral acute mastitis in a lactating woman: a case report and literature review.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Malignant melanoma, an aggressive neoplasm with high metastatic potential, rarely metastasizes to the breast, with bilateral involvement being exceptionally uncommon. This case report details a 36-year-old postpartum woman who presented with bilateral, symmetrical, rock-hard breast swelling and erythema, initially misdiagnosed as severe lactational mastitis. Comprehensive evaluation ultimately revealed diffusely metastatic malignant melanoma. The primary site was identified as a previously excised cutaneous lesion on the chest wall, originally reported as a benign compound nevus. The patient exhibited a rapidly progressive and refractory disease course, failing to respond to sequential targeted therapy, immunotherapy, and chemotherapy, and succumbed to the disease within seven months of diagnosis. This case underscores a profound diagnostic pitfall, highlighting the potential for metastatic melanoma to mimic benign inflammatory breast conditions, particularly in the physiologically altered postpartum period. It emphasizes the critical need for a high index of suspicion for metastatic disease in atypical breast presentations and reinforces the imperative of meticulous history-taking, including a thorough review of all prior skin pathology, in patients with malignancy of unknown origin. The aggressive clinical course further illustrates the formidable therapeutic challenges in such advanced presentations of metastatic melanoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.